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Enterohemorrhagic Escherichia coli (EHEC) constitutes a group of E. coli that in the past two decades 
has been the cause of several outbreaks of gastrointestinal disease. The microorganism causes 
hemorrhagic colitis (HC) and haemolytic uremic syndrome (HUS) in 5-10% of the patients, 30% of 
the HUS patients develop remaining kidney injuries. The capacity to control EHEC disease and to 
limit the scale of outbreaks is dependent upon prompt diagnosis and identification of the source of 
infection. 
Cattle are the principal reservoir of EHEC and foodstuffs, which presumably have come into 
contact with domestic animal manure and/or are inadequately pasteurised, are important vehicles of 
infection. 
The predominating virulence factor of EHEC is the verocytotoxin first identified in an E. coli of 
serogroup 0157:H7. In the present study, the PCR technique with primers detecting the verocytotoxin 
genes was shown to be a fast, sensitive and specific method to screen for and identify EHEC. The 
study contributes to the knowledge and understanding that also EHEC non-0157 are pathogenic and 
that all verocytotoxin producing E, coli should be looked after among patients with diarrhoea, HC and 
HUS. 
The importance of quick identification was exemplified in an outbreak of EHEC among the 
staff at the children's hospital in Göteborg, Sweden. As the outbreak was promptly identified, partly 
thanks to the PCR technique, no further spread to other staff members or patients occurred. 
In the present thesis, pulsed-field gel electrophoresis (PFGE) was used and the method was 
shown to be very useful in the epidemiological work to separate single cases of EHEC from outbreaks. 
In order to further characterise EHEC non-0157, the presence of additional chromosomal and 
plasmid genes probably involved in the pathogenesis were analysed as these genes have been found in 
EHEC 0157. The gene coding for intimin, enabling tight attachment to epithelial cells of the intestine 
was also often present among EHEC non-0157. Moreover, the gene coding for an enterohemolysin 
possibly supporting the bacterial need for iron was especially often present among EHEC isolated 
from patients with severe symptoms. 
Further, the study has shown that the gene coding for aerobactin seems to be able to compensate 
for the absence of enterohemolysin and that also the type 1 fimbriae may be valuable to obtain a niche 
in the gut. 
A comparative study of verocytotoxin producing E. coli in cattle showed that there is a signifi­
cantly lower amount of E. coli harbouring the intimin gene and the gene coding for aerobactin, 
supporting the assumption that not all verocytotoxin producing E. coli in cattle are pathogenic. 
In conclusion, methods identifying the verocytotoxines or their genes should be used to identify 
EHEC of all serogroups. PCR is preferable as it is a fast, sensitive and specific method. Genes coding 
for intimin, enterohemolysin and aerobactin adds to the pathogenicity of EHEC. These genes are not 
that common among isolates from cattle. PFGE is a most valuable tool for epidemiological tracing of 
EHEC, 
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ABSTRACT 
Enterohemorrhagic Escherichia coli (EHEC) 
Microbiological Diagnosis, Characterisation and Clinical Bacteriological Aspects 
Christina Welinder Olsson 
Institute of Laboratory Medicine, Department of Clinical Bacteriology, 
Göteborg University, Guldhedsgatan 10, SE-413 46 Göteborg, Sweden 
Enterohemorrhagic Escherichia coli (EHEC) constitutes a group of E. coli that in the past two 
decades has been the cause of several outbreaks of gastrointestinal disease. The micro­
organism causes hemorrhagic colitis (HC) and haemolytic uremic syndrome (HUS) in 5-10% 
of the patients, 30% of the HUS patients develop remaining kidney injuries. The capacity to 
control EHEC disease and to limit the scale of outbreaks is dependent upon prompt diagnosis 
and identification of the source of infection. 
Cattle are the principal reservoir of EHEC and foodstuffs, which presumably have come 
into contact with domestic animal manure and/or are inadequately pasteurised, are important 
vehicles of infection. 
The predominating virulence factor of EHEC is the verocytotoxin first identified in an 
E. coli of serogroup 0157:H7. In the present study, the PCR technique with primers detecting 
the verocytotoxin genes was shown to be a fast, sensitive and specific method to screen for 
and identify EHEC. The study contributes to the knowledge and understanding that also 
EHEC non-0157 are pathogenic and that all verocytotoxin producing E. coli should be looked 
after among patients with diarrhoea, HC and HUS. 
The importance of quick identification was exemplified in an outbreak of EHEC among 
the staff at the children's hospital in Göteborg, Sweden. As the outbreak was promptly 
identified, partly thanks to the PCR technique, no further spread to other staff members or 
patients occurred. 
In the present thesis, pulsed-field gel electrophoresis (PFGE) was used and the method 
was shown to be very useful in the epidemiological work to separate single cases of EHEC 
from outbreaks. 
In order to further characterise EHEC non-0157, the presence of additional chromo­
somal and plasmid genes probably involved in the pathogenesis were analysed as these genes 
have been found in EHEC 0157. The gene coding for intimin, enabling tight attachment to 
epithelial cells of the intestine was also often present among EHEC non-0157. Moreover, the 
gene coding for an enterohemolysin possibly supporting the bacterial need for iron was 
especially often present among EHEC isolated from patients with severe symptoms. 
Further, the study has shown that the gene coding for aerobactin seems to be able to 
compensate for the absence of enterohemolysin and that also the type 1 fimbriae may be 
valuable to obtain a niche in the gut. 
A comparative study of verocytotoxin producing E. coli in cattle showed that there is a 
significantly lower amount of E. coli harbouring the intimin gene and the gene coding for 
aerobactin, supporting the assumption that not all verocytotoxin producing E. coli in cattle are 
pathogenic. 
In conclusion, methods identifying the verocytotoxines or their genes should be used to 
identify EHEC of all serogroups. PCR is preferable as it is a fast, sensitive and specific 
method. Genes coding for intimin, enterohemolysin and aerobactin adds to the pathogenicity 
of EHEC. These genes are not that common among isolates from cattle. PFGE is a most 
valuable tool for epidemiological tracing of EHEC. 
Key words: Escherichia coli, EHEC, VTEC, verocytotoxin, PFGE, EHEC-hemolysin, aerobactin, diarrhoea, HUS 
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ABBREVIATIONS 
A/E attaching and effacing 
bp base pair 
CFU colony forming unit 
CNS central nervous system 
CNF 1 cytotoxic necrotizing factor type 1 
EAEC enteroaggregative Escherichia coli 
EHEC enterohemorrhagic Escherichia coli 
E-hly EHEC-hemolysin 
E1EC enteroinvasive Escherichia coli 
ELISA enzyme-linked immunosorbent assay 
EPEC enteropathogenic Escherichia coli 
ETEC enterotoxigenic Escherichia coli 
HC hemorrhagic colitis 
HUS hemorrhagic uremic syndrome 
kbp kilo base pair 
LEE locus for enterocyte effacement 
ML VA multiple-locus variable-number tandem-repeats analysis 
ND not done 
OMP outer membrane protein 
ORF open reading frame 
PCR polymerase chain reaction 
PFGE pulsed-field gel electrophoresis 
RAPD randomly amplified polymorphic DNA 
RBC eiythrocytes 
RTX repeat-toxins (pore-forming cytotoxin) 
SMAC sorbitol-MacConkey (medium) 
VNTR variable tandem tandem repeat 
VT Vcrotoxin/V erocytotoxin 
VTEC Verocytotoxin-producing E. coli 
Genes 
chu A E. coli haem-utilization gene 
daaE F1845 fimbriae, major subunit gene 
eaeA E. coli attaching and effacing gene, intimin 
E-hly EHEC-hemolysin gene 
espP Extracellular serine protease, plasmid encoded 
etpD EHEC type II secretion pathway 
fimA Type 1 fimbriae, major subunit gene 
hlyA a-hemolysin, toxin precursor gene 
hlyCABD hemolysin operon 
iutA aerobactin, iron uptake transport receptor gene 
katP Catalase-peroxidase, plasmid encoded gene 
papC P fimbriae, pyelonephritis-associated pili, assembly platform gene 
sfaD/sfaE S fimbrial adhesin gene 
VT1 Verocytotoxin 1 
VT2 Verocytotoxin 2 
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INTRODUCTION 
The recognition of EHEC (enterohemorrhagic Escherichia coli) as an etiological 
agent of diarrhoea with life-threatening complications has made this kind of in­
fection a public health problem of serious concern. The pioneering work leading 
to the discovery of the E. coli verocytotoxins (VTs) was done by Konowalchuk 
and colleagues during the late 1970s (Konowalchuk 1977). They reported the 
feature of the production of a toxin with a profound and irreversible cytopathic 
effect on Vero (African green monkey kidney) cells. O'Brien et al. purified and 
characterised the cytotoxin and found that it had a similar structure and biologi­
cal activity as the Shiga toxin produced by Shigella dysenteriae type 1 (O'Brien 
1982, O'Brien 1983). In the early 1980s, verocytotoxin producing E. coli were 
linked to two conditions of previously unknown cause, hemorrhagic colitis (HC) 
and haemolytic uremic syndrome (HUS) (Karmali 1983, Riley 1983). Addi­
tionally, isolates of verotoxigenic E. coli belonged to a previously rare sero-
group 0157:H7 (Karmali 1983, Riley 1983, CDC Centers for Disease Control. 
1982) and this serogroup has been the type most commonly associated with 
large outbreaks (Ostroff1990, Swerdlow 1992, Fukushima 1999). 
The major justification for continued interest in EHEC infections from a clinical 
perspective is the high rate of serious complications associated with this infec­
tion, especially in children. HUS, which defined by a triad of features: acute 
renal failure, thrombocytopenia, and microangiopathic haemolytic anemia, 
occurs in 2-15% of cases (Carter 1987, Slutsker 1997, Rowe 1998). The mor­
tality from HUS is high (3-17%) (Griffin 1991), and has been reported to be 
even higher among elderly (Carter 1987). A significant number (approximately 
30%) suffer a range of permanent disabilities, including chronic renal insuffi­
ciency, hypertension, and neurological deficits (Karmali 1989, Tarr 1995). 
The pathogenesis invol ves establishment of the organism in the gut, where it has 
to compete for space and nutrients with other microorgansims of the normal in­
testinal microflora. The most important virulence characteristic of the organism, 
once established, is its ability to produce one or more phage encoded verocyto­
toxins (VT1 and VT2) (Paton 1998b). Toxin production mediates both local and 
systemic disease. Local intestinal effects cause the development of bloody 
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diarrhoea as the toxin has internalised the cells of the gut where it blocks cellular 
protein synthesis and may lead to apoptosis. HUS results from microvascular 
disease when the toxins enter the bloodstream and bind to receptors on endothe­
lial cells abundant in kidneys and brain (Nataro 1998). 
VT producing E. coli can be found in the faecal flora of a wide variety of ani­
mals but the most important animal species in terms of human infection is cattle. 
The bacteria are usually isolated from, healthy animals but may be associated 
with an initial episode of diarrhoea in young animals followed by asymptomatic 
colonization (Nataro 1998). 
The nomenclature has been somewhat confusing with the systems EHEC, VTEC 
(verocytotoxin E. coli) and STEC (Shiga-like toxin E. coli) used interchangeably 
in the literature. In this thesis, EHEC will be used for verocytotoxin producing 
E. coli in humans and VTEC for verocytotoxin producing E. coli found in 
healthy cattle. 
REVIEW OF THE LITERATURE 
EHEC in humans, pathogenesis and virulence factors 
The expression of one or both of the verocytotoxin genes is the main feature of 
EHEC. Pathogenesis is, however, a multistep process, involving the interactions 
between several additional bacterial and host factors. Virulence factors studied 
in this thesis are presented in Table 1. 
The infectious dose of EHEC is very low, between 1 and 100 CFU, which is a 
much lower dose than for most other pathogens of the intestines (Paton 1998b). 
Ingested EHEC must pass the stomach and then find an ecological niche in the 
gut competing for space and nutrients with other microorganisms to establish 
colonization. One of the main determinants of EHEC to cause disease in humans 
is their ability to adhere to intestinal epithelial cells and to colonize the human 
gut. The processes of establishment and maintenance of colonization of the 
intestines are not fully understood but interesting efforts for therapeutic inter-
8 
vention has been made involving interference with these processes (Dean-
Nystrom 2002). 
VT produced, is transported to receptors on target cell surfaces inducing patho­
logical effects. To reach the receptors the toxins after being produced in the 
lumen must be absorbed by the intestinal epithelium and then translocated to the 
bloodstream. 
Table 1. The EHF.C/VTEC isolates of human and cattle origin were characterized for the 
following possible virulence factors 
Virulence factors gene P*/C** Proven/possible importance Ref.*** 
Verocytotoxin 1 VT1 c - Inhibit protein synthesis, 1 
Verocytotoxin 2 VT2 C , causing cell death 
Intimin eaeA C Mediates intimate adherence to 2 
epithelial cells 
EHEC-hemolysin E-hly p Hemolytic to washed sheep 3 
RBC 
Type II secretion etpD p Secrete extracellular proteins 4 
Catalase- katP p Defence against oxidative 5 
peroxidase stress etc. 
Serine protease espP p Cleaves coagulation factor V 
pfp 
6 
Type 1 fimbriae fimA c ] 
Civ. 
7 
P fimbriae papC c Adhesins that enable adherence 8 
S fimbriae sfaD/sfaE C to host cells 9 
F 1845 daaE c 10 
Aerobactin iutA c Mediates bacterial iron 11 
acquisition 
a-hemolysin hlyA c Osmotic lysis of target cells 12 
* P = plasmid 
** C = chromosomal 
*** 1 (O'Brien 1992, Melton-Celsa 1998, Scheutz 2001), 2 (Jer se 1990), 3 (Schmidt 1995, 
Schmidt 1996b), 4 (Schmidt 1997), 5 (Brunder 1996), 6 (Brunder 1997), 7 (Duguid 
1955), 8 (Leffler 1981), 9 (Parkkinen 1983, Ott 1986), 10 (Bilge 1989), M (Neilands 
1985, Johnson 1988), 12 (Rennie 1974, Seeger 1989, Suttorp 1990) 
Attaching and effacing adherence 
A number of enteropathogenic bacteria, including both enteropathogenic 
Escherichia coli (EPEC) and EHEC, cause attaching-effacing (A/E) lesions. A/E 
bacteria generally infect the small or large intestine and cause diarrhoea. The 
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mechanism whereby EHEC isolates generate A/E lesions is similar as for EPEC. 
The A/E lesion, first reported by Staley et al (Staley 1969), is characterized by 
intimate attachment of the bacterial cell to the intestinal epithelial cell mem­
brane with destruction of the microvilli and disruption of the cellular cytoskele-
ton at the site of attachment. All A/E bacteria have a chromosomal pathogenicity 
cassette, called LEE (for locus of enterocyte effacement), which is a 35-kb 
region of DNA that encodes the gene products necessary for formation of the 
A/E lesion (McDaniel 1995, Rosenshine 1996). 
Donnenberg and Kaper proposed a three-stage model of EPEC pathogenesis 
(Donnenberg 1992b) consisting of: local adherence, signal transduction and 
phosphorylation of host proteins and intimate adherence. In EPEC local 
adherence is mediated by so called bundle-forming pili (Donnenberg 1992a) 
encoded by a plasmid gene. However isolates of EHEC do not carry this plasmid 
and lack genes coding for bundle forming pili (Willshaw 1992, Beutin 1995, 
Wieler 1996). 
One factor part of the LEE cassette that promotes intimate adherence, is the 
product of the gene eaeA, a 94-kDa outer membrane protein (OMP) called 
intimin (Jerse 1990). The eaeA gene has been identified in both EPEC and 
EHEC and has a sequence homology in the two bacteria of 86% (Yu 1992). 
Mutation of the eaeA locus results in loss of the ability to produce the attaching 
and effacing effect both in isolates of EPEC and EHEC (Donnenberg 1991, 
Donnenberg 1993). 
The host epithelial receptor for intimin named Tir (translocated intimin receptor) 
(Rosenshine 1996) is also encoded by LEE (Kenny 1997) in both EPEC and 
EHEC. The protein is secreted from the bacteria and for efficient delivery into 
the host cell, dependent upon the type III secretion system and other LEE-
encoded proteins (Jarvis 1996, DeVinney 1999). 
Notwithstanding the above, a significant minority of human EHEC isolates, in­
cluding those from patients with HC and HUS, have been observed not to con­
tain eaeA, indicating that intimin is not essential for human virulence (Barrett 
1992, Louie 1994). 
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Fimbriae 
Fimbriae or fimbrial adhesins are thread-like structures that reach out from the 
bacterial surface enabeling bacteria to adhere to host cells. 
Type 1 fimbriae were the adhesins first described in E. coli (Duguid 1955). They 
are the most common adhesins produced by these bacteria and mediate ad­
herence to mannose-containing glycoproteins found on the surfaces of many 
eukaryotic cells (Johnson 1991). More than 90% of E. coli isolates from the gut 
of healthy Swedish adults have the genes for type 1 fimbriae (Friman 2002). 
However, the type 1 fimbriae have also been shown to play an important role in 
the colonization of E. coli in the human urinary tract and, from their prevalence, 
it is assumed that they are important in the faecal-oral cycle, for binding within 
the gastrointestinal tract and/or for transfer between hosts (Orndorff1990). 
Type 1 fimbriae are encoded by the fim gene cluster, fimA-H (Abraham 1987, 
Abraham 1988). The expression is regulated by phase variation within the pro-
motor offimA. Enami M. et al. (Enami 1999) showed, however, that VT pro­
ducing E. coli 0157 strains appeared unable to express type 1 fimbriae while 
other serotypes such as 026 and 0118 could. The molecular basis of this dif­
ference is the presence of a 16 bp deletion within the regulatory region of fimA 
in EHEC 0157 but not in other EHEC serotypes tested (Li 1997, Roe 2001). 
EHEC expressing type I fimbriae may have increased possibility to colonize the 
gut. Initial adherence by factors such as type 1 fimbriae may make subsequent 
intimate adherence and A/E lesion formation more likely to occur (Mack 1999) 
as the adhesin, bundle-forming pili, known to be involved in EPEC A/E lesions, 
is not present among isolates of EHEC. 
P fimbriae (Leffler 1980), with the adhesin papG, recognize the Galal—>4Galß 
disaccharide of uroepithelial cells and human erythrocytes (Leffler 1981). The 
pap operon consists of 11 genes and the pap C gene product is located in the 
outer membrane forming the platform for fimbrial growth (Kuehn 1994). P 
fimbriae are especially associated with urinary tract infections but have even 
been found among faecal isolates (Johnson 1991). 
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S fimbriae are adhesins also expressed by some isolates from urinary tract infec­
tions (Ott 1986). The receptor is terminal sialyl-galactoside residues (Parkkinen 
1983, Parkkinen 1989). The S fimbrial adhesin is located at the fimbrial tips 
(Moch 1987) and, as with P fimbriae, has a different amino acid sequence than 
the structural subunit (Hacker 1985b, Moch 1987). The structural subunit shares 
N- and C-treminal amino acid sequence homology with the P fimbriae and, like 
other E. coli fimbrial subunits, it contains an internal disulfide loop (Schmoll 
1990). The expression of S fimbriae is subjected to phase variation by methyla-
tion of nucleotides in the regulatory region, similar to the case with P fimbriae 
(Saukkonen 1988, van der Woude 1994). The sfa operon consists of 9 genes and 
sfaE is involved in the transport of subunit proteins (Schmoll 1990). 
Fl845 is one of four adhesins that belongs to the Dr family of adhesins (Nowicki 
1990). These adhesins recognize distinct receptor epitopes on decay-accelerating 
factor (DAF), a membrane protein involved in regulation of the complement 
cascade (Nowicki 1993). While three of the adhesins are isolated from patients 
with urinary tract infections, F1845 is a fimbrial adhesin of diarrhoea-associated 
E. coli (Bilge 1989). The adhesin confers upon E. coli the ability to adhere to 
cultured epithelial cells in a diffuse pattern, with bacteria distributed evenly over 
the surface of the cells (Bilge 1993a). The determinant encoding the expression 
of F1845 consists of at least six genes, designated daaA-daaF (Bilge 1989, Bilge 
1993b). The gene (daaE) encoding the major fimbrial subunit, which also serves 
as the adhesin is located at the 3' end of the locus (Swanson 1991). 
Bacterial need for iron 
It is well known that iron is needed by all living cells (Weinberg 1978). E. coli 
uses iron for oxygen transport and storage, DNA synthesis, electron transport, 
and metabolism of peroxides (Neilands 1985, Bagg 1987). Almost all iron in 
biological fluids is, however, complexed with host iron proteins. A host defence 
mechanism against bacterial infection is to further reduce the amount of iron 
available to the invading pathogen (Weinberg 1978). Thus, bacteria need effec­
tive systems to meet their iron needs during infection. 
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In E. coli, the siderophore aerobactin is the most effective of the several iron 
chelation systems employed by enteric bacteria for iron acquisition (Warner 
1981, Bindereif 1985, Neilands 1985, Williams 1986, Bagg 1987). After secre­
tion of aerobactin by E. coli cells, it can extract Fe3+ from host iron-binding 
proteins and be taken up through an outer membrane protein (OMP) receptor 
(Carbonetti 1984, de Lorenzo 1986b). Isolates with the aerobactin system have a 
growth advantage in low-iron conditions (Williams 1979, Braun 1984, 
Montgomerie 1984) and, in comparison to the other major specialized sidero­
phore, enterobactin, aerobactin is more effective. Aerobactin has a higher 
affinity constant for iron than enterobactin at neutral pH (Bagg 1987), and aero­
bactin deferrates transferrin more rapidly in serum or in the presence of albumin, 
presumably because enterobactin (but not aerobactin) binds to and is inactivated 
by proteins (Warner 1981, Braun 1984, Williams 1986, Bagg 1987, de Lorenzo 
1988). Enterobactin is less soluble and less stable than aerobactin (Warner 1981, 
de Lorenzo 1988) and aerobactin is also continuously recycled without hydroly­
sis (Braun 1984) in contrast to enterobactin where the release of iron requires 
hydrolysis of the siderophore (Warner 1981). Aerobactin delivers iron directly 
to bacterial iron centers, whereas enterobactin leaves iron free in the cytosol 
(Williams 1986). Enterobactin binds to serum proteins, and gives rise to anti-
enterobactin antibodies that probably limits its use as a siderophore in vivo 
(Bindereif 1985). Finally, aerobactin production is stimulated by milder degrees 
of iron deprivation than are required to stimulate enterobactin production 
(Williams 1986, de Lorenzo 1988). 
In most isolates of E. coli, aerobactin is expressed by five opérons, iucA-D and 
iutA (de Lorenzo 1986a). lutA is coding for the OMP receptor protein. Aero­
bactin determinants are found both on plasmids and on the bacterial chromo­
some. The chromosomal location is, however, most common among human iso­
lates (Valvano 1986, Johnson 1988). 
Aerobactin has been found to be rarely expressed by isolates of ETEC, on the 
contrary EPEC and EIEC isolated from humans and from domestic animals with 
sepsis and mastitis do (Williams 1985, Linggood 1987). The expression of aero­
bactin is poorly studied among isolates of EHEC. 
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a-hemolysin is a cytolytic protein toxin that lyses erythrocytes of all mammals 
and even fish (Rennie 1974, Cavalieri 1984). It is encoded by a four-gene 
operon termed hlyCABD (Goebel 1982, Johnson 1991), which is located on the 
chromosome in human isolates of E. coli (Welch 1983, Johnson 1988). The hlyA 
gene encodes the structural hemolysin protein (Waalwijk 1984, Welch 1984) and 
this must be activated by the protein encoded by hlyC (Felmlee 1985, Nicaud 
1985) prior to its secretion. HlyB and D are involved in the secretion of the hlyA 
determinant (Hacker 1985a, Wagner 1988). The provirulence activity of hemo­
lysin is probably multifactorial and includes the release of iron from erythro­
cytes, disruption of phagocyte function, and direct toxicity to host tissues 
(Johnson 1991). Even though a-hemolysin is often expressed among haemolytic 
E. coli isolates (Cavalieri 1984), it seems to be unusual among isolates of EHEC 
(Law 1995). 
The plasmid p0157 
Many bacterial pathogens are known to carry plasmids that encode important 
virulence factors. The plasmids often carry genes responsible for the expression 
of their group-specific pathogenicity, e.g. the heat-labile and heat-stable toxins 
of enterotoxigenic E. coli. (ETEC), the invasion factors of enteroinvasive E. coli 
(EIEC), the aggregative adherence fimbriae mediating the typical phenotype of 
enteroaggregative E. coli (EAEC) or the virulence factor bundle forming pili of 
enteropathogenic E. coli (EPEC) (Nataro 1998). Virtually all EHEC isolates 
carry large plasmids about 75-100 kb in size, which were thought to be impli­
cated in the pathogenesis of EHEC (Bopp 1987, Ostroff 1989, Fratamico 1993, 
Paros 1993). Plasmid p0157, 90 kb large and present in almost all EHEC 0157 
isolates, was first detected in isolates causing an outbreak of HC (Wells 1983). 
This plasmid has been the subject of several investigations. 
Schmidt et al. characterized the plasmid p0157 by restriction mapping and de­
scribed a p0157-encoded determinant, designated EHEC-hemolysin (Schmidt 
1995, Schmidt 1996b). EHEC-hemolysin is a member of the RTX (Repeats in 
toxin) family of pore-forming cytolysins and was shown to be cytotoxic for 
human and bovine cell lines (Bauer 1996). Isolates producing this enterohemo-
lysin are not hemolytic on standard blood agar but produce small, turbid hemo-
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lytic zones on washed sheep RBC agar after over night incubation (Beutin 
1989). EHEC-hemolysin consists of four open reading frames with 60% ho­
mology to the E. coli a-hemolysin operon (hlyCABD), and the 0157 entero-
hemolysin operon was therefore named EHEC-hlyCABD (Schmidt 1995, 
Schmidt 1996b). E-hlyA is the structural gene for the enterohemolysin. The 
enterohemolytic phenotype is, however, associated with defective hemolysin 
secretion. Moreover, by transforming the type strain EDL 933 with the hlyB and 
hlyD genes derived from the a-hemolysin operon, this defect could be com­
pleted, resulting in an a-hemolytic phenotype. Schmidt et al. (Schmidt 1995) 
analysed isolates of EHEC 0157:H7, as well as 0157:H45 and some non-0157 
EHEC. All EHEC 0157:H7 and 50% of VTpositive EHEC non-0157 harboured 
the E-hly gene, while all isolates negative for VT genes were negative for E-hly. 
Thus, there seemed to be a correlation between VT and enterohemolysin 
production, especially in 0157 isolates. The manner in which E-hly may 
contribute to the pathogenesis of EHEC disease is possibly that hemoglobin 
released by the action of the hemolysin provides a source of iron, thereby 
stimulating the growth of EHEC in the gut. 
The second p0157-encoded determinant discovered, was the EHEC katP 
catalase-peroxidase, which is produced in addition to the two chromosomally 
encoded catalases or hydroperoxidases of E. coli (Brunder 1996). Catalases are 
part of the bacterial defence mechanisms against oxidative stress (Farr 1991), 
while the peroxidases are haem binding enzymes that carry out a variety of 
functions using hydrogen peroxid as the electron acceptor (Loewen 1985, 
Triggs-Raine 1988). Brunder et al. (Brunder 1996) analysed by PCR, 
representative isolates of the major groups of diarrhoeagenic E. coli, including 
EPEC, EIEC, ETEC, EAEC, EHEC 0157 and non-0157 for presence of the 
katP gene. The results of the experiment showed that the katP gene was 
prevalent in EHEC isolates of serogroup 0157 that also harboured the EHEC-
hemolysin operon and 1/3 of the E. coli of two serogroups tested of non-0157 
EHEC (026 and Olli) were also katP positive. The EPEC, ETEC, EIEC and 
EAEC isolates were all negative in the PCR assay. 
The plasmid also harbours a gene with great similarities to genes of members of 
the type II secretion pathway systems of Gram-negative bacteria used to secrete 
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extracellular proteins. The gene encloses 13 open reading frames (ORF) named 
etpC-O (Schmidt 1997). The ORF etpD has a sequence similarity of 70.0% to 
pulD, which is a related gene sequence of Klebsiella pneumoniae (Schmidt 
1997). Hybridization experiments with a specific etp probe and various catego­
ries of enteric E. coli pathotypes revealed that the etp gene cluster occurred in 
100% of EHEC 0157 tested and among 60% of EHEC of other serogroups. It 
was not found in isolates of EPEC, ETEC, EIEC or EAEC (Schmidt 1997). 
Brunder et al. identified and characterized in 1997 an extracellular serine 
protease espP, which is encoded by p0157 (Brunder 1997). The corresponding 
espP gene showed to consist of one ORF encoding a 1300-amino acid protein. 
The deduced amino acid sequence had homology to several secreted or surface-
exposed proteins of pathogenic bacteria, for example, espC of EPEC. There is 
70% homology between the EHEC espP and the EPEC espC. Functional tests 
showed that the espP gene codes for a protease capable of cleaving pepsin A and 
human coagulation factor V. Thus Brunder et al. have suggested that secretion 
of the espP by EHEC in the gut could result in the mucosal hemorrhage 
observed in patients with hemorrhagic colitis (Brunder 1997). 
Verocytotoxin (VT) types and mode of action 
The most important virulence characteristic of EHEC, once established in the 
gut, is its ability to produce VTs. They belong to a group of toxins with the 
prototype toxin produced by Shigella dysenteriae serotype 1. EHEC may pro­
duce one or more related toxins designated VT1 and VT2 with five and twelve 
variants respectively (O'Brien 1992, Melton-Celsa 1998, Scheutz 2001). VT1 is 
most closely related to the Shiga-toxin produced by S. dysenteriae, differing by 
only one amino acid in the A-subunit of the toxin. VT1 and VT2 are approxi­
mately 56% homologous at the deduced amino acid sequence level, while the 
variants of VT2 are 84-99% homologous to VT2 (Melton-Celsa 1998). The VT 
genes are encoded by lambdoid bacteriophages which lysogenize EHEC 
(Schmidt 2001a). 
All the VTs are AB5 toxins consisting of a single 32 kDa A-subunit in non-
covalent association with a pentamer of identical B-subunits. X-ray crystallo-
graphic analysis demonstrated that the B-subunit pentamers form a ring structure 
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with the carboxy-terminus of the A-subunit inserted into the central pore of B-
subunits (Fraser 1994). Toxin binding to cells is mediated by the B-subunits 
through interaction with globotriaosylceramide (Gb3) in host cell membrane. 
Gb3 is expressed on epithelial and endothelial cells derived from a variety of 
sites in both humans and animals (Lingwood 1996). Once VTs bind their glyco-
lipid receptors, the toxins are transported through the trans-Golgi network and 
Golgi apparatus to the endoplasmic reticulum (ER) and nuclear membrane. This 
pattern of intracellular trafficking is referred to as retrograde transport (Sandvig 
2002). During this transport, the A-subunit is cleaved by furin, a calcium-
sensitive serine protease localized to the Golgi network. The resultant A-subunit 
fragments, A] + A2, remain associated by a disulfide bond. An alternative 
mechanism of A-subunit processing involving the action of the protease calpain 
has also been described (O'Loughlin 2001). Once in the ER, the disulfide bond 
linking A\ + A2 is reduced, and the Aj fragment is translocated across the ER 
membrane into the cytoplasm. The A) fragments of VTs catalytically cleave a 
single adenine residue from the 28S rRNA component of the eukaryotic ribo-
somal 60S subunit. Following depurination, elongation factor 1-dependent 
aminoacyl-tRNA binding is inhibited thereby inhibiting the peptide chain 
elongation step of protein synthesis and ultimately causing cell death (O'Brien 
1992). 
Role of the verocytotoxin genes in pathogenesis 
The characteristic intestinal damage caused by EHEC includes hemorrhage and 
edema in the lamina propria with focal necrosis and neutrophil infiltration. It has 
recently been shown that VT 1 and VT2 are translocated across polarized intesti­
nal epithelial monolayers and, in this way, penetrate the epithelium (Philpott 
1997, Hurley 1999). The VT's can, in this way, get access to and damage the 
colonic blood vessels. VTs have also been shown to induce the expression of the 
neutrophil-specific chemokine interleukin-8 by human intestinal epithelial cells 
in vitro (Thorpe 1999), in other words - it seems like VTs do participate in the 
process of gut inflammation. It has also been shown that VT1 almost exclusively 
binds neutrophils when incubated with human whole blood (Te Loo 2000). 
Moreover VT2, in the bloodstream of HUS patients, has been associated with 
neutrophils (Te Loo 2001). Additionally, Te Loo et al. (Te Loo 2000) have found 
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that VT 1 was easily transferred from neutrophils to the surface of tumor necrosis 
factor-a (TNF-a)-treated human glomerular microvascular endothelial cells in 
vitro. From these data Cherla et al. (Cherla 2003) made the following 
conclusions that the toxins (i) possess the mechanism to cross the intestinal 
epithelial barrier; (ii) induce a neutrophil-rich inflammatory infiltrate in the gut; 
and (iii) in the bloodstream take a lift on neutrophils which mediate the transport 
to tissues with high-affinity receptors. The presence of VTs in the circulation 
appears to be a critical determinant in the development of HUS and CNS 
complications (Moxley 1998). It is now generally agreed that the major portion 
of the histopathological lesions associated with both HC and HUS is a 
consequence of the interaction of VT with glomerular and CNS microvascular 
endothelial cells (Richardson 1988). An illustration of the process of EHEC 
infection is shown in Fig. 1. 
EHEC 
1 bind 
epithelial cells 
n!/ 
colonozation of the gut 
production of VTs 
translocation of VTs across and between gut epithelial cells 
VTs in the blood stream 
si, 
death of primarily glomerular and CNS microvascular endothelial cells 
after uptake via Gb3 receptors 
Fig. 1. Schematic illustration showing the main features of the pathogenes of human EHEC 
infection 
Sources of human infections and epidemiology 
The first two registered outbreaks in the USA, 1982, in Michigan and Oregon 
respectively, of EHEC 0157:H7 were transmitted by the same source of under­
cooked beef. Since then, it has been shown that ruminants and primarily cattle, 
are the most important reservoir of EHEC (Chapman 1989, Olsvik 1991, 
Pierard 1994, Nielsen 2002). VT producing E. coli are not usually pathogenic 
for adult cattle, although some serogroups can cause diarrhoea in calves 
(Sherwood 1985, Snodgrass 1986, Dorn 1993). Through contamination with 
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faecal material from ruminants, EHEC can be found in many other reservoirs, 
e.g. water, soil, meat, fruit and vegetable products. Vegetables and fruit, under­
cooked meat or inadequately pasteurised dairy products are important vehicles 
of infection. In recent years rabbits and birds have been reported as reservoir 
hosts of EHEC that may pose a zoonotic risk for humans (Garcia 2003, Leclercq 
2003). Even person to person transmission of EHEC is a well-documented 
phenomenon during outbreaks and is probably also a reason for a significant 
portion of sporadic cases (Beutin 1993, Blanco 1996, Paton 1998b). 
Verocytotoxin and other virulence factors in E. coli isolated from cattle 
VT producing E. coli can be readily isolated from the gastrointestinal tract of 
cattle. Several studies in different countries have shown that 10-80% of cattle 
may carry VT producing E. coli (Wells 1991, Beutin 1993, Blanco 1996, 
Cobbold 2000). Isolates harboured by cattle have often been characterised in the 
same way as human isolates using various phenotypic and genetic markers. In­
dividual isolates making up bovine populations of VT producing E. coli may be 
common or diverse both within and between herds and individual animals in 
keeping with the long-known concept of resident and transient E. coli in eco­
logical niches. Of the VT producing E. coli excreted by cattle and potentially 
contaminating meat and other foodstuffs, only a few seem to have the potential 
to cause human illness. The factors involved in this discrepancy are not yet fully 
identified but determinants that are important virulence factors in humans and 
rarely exist in helthy cattle may be candidates. 
VTEC does, however, usually not cause disease in cattle and other ruminants 
which may have helped its successful spread to a large amount of herds of cattle 
(Elder 2000, Gansheroff 2000, Synge 2000). Studies have shown that the 
presence of the eaeA gene and the plasmid, coding for the E-hly gene, is more 
seldom present among non-0157 EHEC isolated from cattle than from humans 
(Barrett 1992, Jenkins 2002). On the contrary verocytotoxin positive 0157 
EHEC isolated from cattle are, however, in a Danish study, always eaeA 
positive and also harbour the plasmid p0157 (Nielsen 2002). 
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Another potential virulence factor is the a-hemolysin. It has in two studies how­
ever been shown to occur at a low frequency among bovine VTEC (Law 1995, 
Sandhu 1997) and VTEC isolated from healthy cattle have only to a low extent 
the ability to use heme or hemoglobin as the source of iron (Law 1995). 
The capacity to use iron by the presence of aerobactin was identified by Fectau 
et al. to be an important feature among E. coli (not necessarily VTEC) found in 
the blood of bacteremic calves (Fecteau 2001). The presence of aerobactin pro­
ducing VTEC, especially in healthy cattle is, however, not well studied. 
Most E. coli has type 1 fimbriae. For cattle, it has been established that type 1 
fimbriae bind well to rumen epithelium in vitro (Galfi 1998). Concerning the 
adhesin genes, S and especially P fimbriae, seems to be common among E. coli 
isolated from cattle with septicemia and diarrhoea. These findings were, 
however, made with no correlation to verocytotoxin-positivity (Berlin 1998). 
F1845 has, however, in one study been shown to be uncommon among VTEC 
isolates of diarrhoeic cattle (Mainil 1993). 
Methods for laboratory identification and isolation of EH EC 
Because of their capacity to cause severe disease, EHEC infections of humans 
have in many countries become notifiable by public health authorities for the 
prevention of outbreaks and further spread of the pathogen among human 
beings. One of the major problems of identifying EHEC is that they resemble 
commensal E. coli in very many aspects apart from producing the VTs. Addi­
tionally, they often occur as a minority of the coliforms in the faecal flora of 
patients. The only way to identify all types of EHEC is the detection of VTs or 
of the genes associated with VT production. A number of biological (cyto­
toxicity tests) and serological tests have been developed for identification of 
VTs produced by the bacteria and genetic methods are used for identification of 
VT1 and VT2 specific sequences, some of which will be discussed here. 
Screening methods, which are not directed to identification of VTs or their 
genes, for example, plate indicator media, such as sorbitol MacConkey (SMAC) 
or enterohemolysin agar and serological typing of putative EHEC isolates, can 
certainly help in isolation of these pathogens but the suspected EHEC isolates 
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have always to be confirmed as such by identification of the VT production 
itself or by the presence of VT genes. 
EHEC of serogroup 0157 is usually, but not always, unable to ferment sorbitol. 
This lias led to the development of SMAC agar medium, from which pale yel­
low colonies can easily be selected from the predominantly red colonies of 
sorbitol-fermenting E. coli (March 1986). However, together with seroaggluti-
nation for serogroup 0157 this will only detect sorbitol negative EHEC 0157 
and thus perpetuate the myth that EHEC 0157 are the only ones that matter. 
Most of the methods currently in use to identify whether EHEC are present in a 
faecal specimen or food, now involve DNA-based techniques. Generally, PCR-
based methods have been successfully applied. Specific oligonucleotides 
(primers) are used to amplify short selected sections of DNA specific for the VT 
genes. Different laboratories use a variety of systems (Thomas J994, Welinder-
Olsson 2002, Pulz 2003). There is, however, not yet any standardized, ready to 
use, PCR kit available. 
The cytotoxicity assay method use tissue cultures (Vero cells) to which faecal 
and other supernatant preparations are applied, for observation of characteristic 
cytopathic effects (Konowalchuk 1977, Karmali 1983). After suitable incubation 
time, 2-4 days, the cells are examined for the specific cytopathic effects. The 
specificity of the tissue culture tests can be improved by employment of VT1 
and VT2 specific neutralizing antisera in order to determine if the cytotoxic 
effect is caused by VTs or by another non-neutralizable toxin present in the 
sample (Karmali 1999). The method should be seen as the gold standard with 
which other tests are compared while it will reveal the presence of hitherto un­
known variants of VTs (Cermelli 2002). It is however a very labour-intensive 
and time consuming test and not really appropriate for the routine diagnostic 
laboratory. 
There are several immunological methods for detection of VTs and, in contrast 
to DNA-based and cell culture assays, they are often commercially available as 
ready to use test kits (Scheutz 2001). These tests are often easy to use and do not 
require specific materials and skills for employment. Even though the assay is 
21 
easy to use, it can prove very time consuming and require the use of many wells 
of a microtitre plate until the EHEC is isolated. However, for the rapid screening 
of human faeces, where generally few samples are expected to be positive, these 
test systems are valuable. 
The isolation of EHEC from a positive sample may cause problems, particularly 
as EHEC are often present in small numbers in the sample and resemble com­
mensal E. coli in their phenotypic and growth characteristics. Colony immuno-
blot or colony hybridisations are recently described techniques, now commer­
cially available (Gallien 1996, Timm 1996, Rüger 2001). The basis for these 
techniques is that colony blots are made from primary or secondary isolation 
plates and the presence of EHEC on these plates is then detected by either im­
munological or nucleic acid probes. When positive blots are noted, they can 
easily be referred back to the original agar plate and the positive colonies and 
studied further. 
Another possibility to isolate potential EHEC from a positive sample is the fact 
that many EHEC produce the EHEC-hemolysin (Beutin 1989). This entero-
hemolysin will show hemolysis on washed sheep-blood agar plates. The general 
utility of this test was futher demonstrated (Bettelheim 1995). However, not all 
EHEC produce enterohemolysin, although most of the important human patho­
genic ones do, and not all enterohemolysin-producing E. coli are EHEC. 
Epidemiological typing of EHEC 
Transmission of EHEC follows three main routes: food- or water-borne infec­
tions, acquisition of disease by direct or indirect contact with animals, and 
person-to-person spread. Typing of EHEC bacteria is an important part of identi­
fying the route of transmission and preventing further spread. It is also valuable 
to be aware of the clonal relatedness between isolates when other traits, for 
example possible virulence factors are investigated. There are quite a few diffe­
rent methods available and some of the most often used will be described here. 
For serogrouping animal sera reactive with the so-called O, K and H antigens on 
the bacterial cell wall, capsule and flagella respectively are used. Suspensions of 
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heat-killed bacteria mixed with antiserum are incubated over night at 50°C and 
agglutination is inspected by microscope (Lidin-Janson 1977). The need for 
antisera against several different O, K and H antigens, however, makes the 
method complicated to perform at most laboratories and is often not discrimina­
tive enough. There are commercially serogrouping test kits available. These, 
however, only detect a few serogroups. 
Random amplified polymorphic DNA (RAPD) PCR is a method based on the 
use of one or a few short primers of arbitrary sequence that are allowed to bind 
under low stringency conditions to various sites on both strands of the template 
DNA (Welsh 1990). The PCR reaction yields a series of products of varying 
size, which if separated by gel electrophoresis, gives a band pattern that repre­
sents a "fingerprint" characterising a particular bacterial isolate. The method is 
fast to perform (1-2 days), but the discriminatory power is not always sufficient. 
Pulsed-field gel electrophoresis (PFGE) utilizes restiction enzymes that cut 
DNA infrequently. Relatively large fragments (50-750 kb) of chromosomal 
DNA are generated. The fragments are then separated by special electrophoretic 
procedures, as DNA fragments larger than 40 kb are not efficiently resolved by 
conventional agarose gel electrophoresis. The DNA fragments cleaved by Xbal 
are too large to be sieved through even the largest pores of the gel matrix. How­
ever, the fragments can be resolved by cyclically altering the orientation of the 
electric field during electrophoresis (Schwartz 1984, Rietman 1997). 
Because intact DNA is required for PFGE analysis, conventional DNA isolation 
methods that cause shearing of DNA are not suitable. DNA isolation procedures 
for PFGE involve entrapment of bacteria in agarose plugs. The bacterial cell 
walls are lysed by treatment of the plug with enzymes and detergent. After ex­
tensive washing of the plug restriction of the remaining DNA is performed with 
enzymes chosen to yield a relatively small number of large restriction fragments. 
Xbal is the enzyme often used for the cleavage of EHEC DNA, and agarose 
plugs containing the restricted DNA are subjected to PFGE. 
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AIMS OF THE STUDY 
The main purpose of this study was to perform molecular biological characteri­
sation of EHEC to improve the diagnostics of the organism and characteristics 
of the infection in order to contribute to the control of EHEC disease in humans. 
The specific aims were: 
1. To show that screening, using PCR, for the VT genes is a well-suited 
method for the diagnosis of EHEC. 
2. To contribute to the understanding that also E. coli non-0157 are 
pathogenic. 
3. To study clinical features such as period of incubation and duration of 
faecal shedding of EHEC in the human gut. 
4. To show that PFGE is a valuable tool for epidemiological typing of 
EHEC. 
5. To identify especially virulent isolates by demonstrating genes that, 
beyond the VT genes, may contribute to the bacterial virulence. 
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MATERIAL AND METHODS 
Patients, clinical specimens and isolates from cattle 
In paper I stool specimens were obtained during 1997 and 1998 from 3,948 
patients. All routine specimens sent to the Bacteriological laboratory, 
Sahlgrenska University Hospital in Göteborg, Sweden, from patients under 15 
years of age with diarrhoea or from older patients with sorbitol-negative colo­
nies on sorbitol-Mac-Conkey agar and/or a reported diagnosis of severe or 
bloody diarrhoea were included. Some individuals were symptom free family 
members of patients with diagnosed EHEC. 
Paper II included EHEC isolates from paper I that were EHEC positive by both 
culture and PCR. It also included an additional 30 isolates from patient speci­
mens sampled as described in paper I, between 1998 to 1999, but the age of the 
included children was below 11 years. 
Paper IV included EHEC isolates described in paper I and II all epidemiologi-
cally unrelated with different PFGE patterns. 13 isolates were of serogroup 
0157 and 18 of the serogroups 08, 022, 046, 076, 091, 0117, 0118, 0121, 
0145 and E43478/86, as well as four OR (rough isolates) and four ON (non-
type able isolates). This paper IV also includes 12 VTEC isolates from healthy 
cattle. One specimen was of serogroup 0157 and 11 of serogroup 01, three 
075, three OR and four ON, respectively. The cattle isolates all had different 
PFGE patterns, one specimen had, however, a pattern similar to one of the 
patient specimens. The cattle were sampled during a prevalence study in 1999 
performed by the National Veterinaiy Institute in Uppsala. 
Paper III describes an outbreak where 59 staff members of the children's hospi­
tal in Göteborg with gastrointestinal symptoms were sampled, 37 of whom had 
attended a party. All six kitchen staff members were sampled for EHEC, as well 
as patients at the hospital with symptoms suggesting EHEC infection. The buffet 
served at the party consisted of peanuts, prawns in warm sauce, grated carrots, 
chicken and lettuce served with mangojuice and wine. No food remained to be 
sampled, however, carrots and lettuce from the wholesaler who had supplied the 
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vegetables for the party were analysed for verocytotoxin-producing bacteria 
with PCR and cultured for detection of EHEC. 
All stool specimens were also cultured for Salmonella, Campylobacter, Shigella, 
and Yersinia species. 
Isolation of chromosomal DNA and plasmids 
Bacterial growth from the primary agar plate culture of the stool specimens was 
suspended in 4 ml of double-distilled, sterile water to McFarland 4. One milli­
litre of the suspension was transferred to a centrifugation tube. This sample was 
heated to 100°C in a block thermostat for 15 min. before centrifugation at 7000 
x g for 1 min. A 5 JLII aliqu ot of the supernatant was used for each PCR. Single 
VT1/VT2 positive colonies were analysed by PCR after suspension and boiling 
in 100 (il double-distilled, sterile water. Five microlitres of the supernatant was 
used for each PCR. 
Plasmids were prepared from the isolates according to the manufacturers' 
(Qiagen, VWR, Göteborg, Sweden) instructions for large plasmids. One milli­
litre of overnight culture of EHEC resulted in a plasmid preparation dissolved in 
50 [il of 10 mM Tris-HCl, pH 8.5. 
Screening for V TI ,  V T 2  and eaeA genes by PCR 
Primers used for detection of the VT1/VT2 and eaeA gene sequences were 
designed by S. Löfdahl, Smittskyddsinstitutet, Sweden (Table 2). In paper I, the 
three PCR reactions were performed separately under the same conditions ex­
cept for the primer content. The 50 ul reaction mixture contained 20 mM 
(NH4)2S04, 75 mM Tris-HCl (pH 9.0), 0.01% (w/v) Tween, 1.5 mM MgCl2, 100 
|iM (each) dNTP and 1.25 U Taq DNA polymerase (Advanced Biotechnologies, 
UK). 10 pmol of each primer belonging to each primer pair was added. The 
amplification was performed using an Automatic Cycler (DNA thermal cycler 
9600; Applied Biosystems, Sweden), using an initial modifying denaturation 
step of 4 min. at 96°C, followed by 20 sec. at 94°C, 45 sec. at 55°C and 10 sec. 
at 72°C. The amplified fragments were separated in 2% agarose gel stained with 
ethidium bromide. Primers VTI/ and VTlr, VT2/ and VT2r, and eaeA/ and 
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eaeAr gave PCR fragmenst of 130 bp, 298 bp and 376 bp in length, respectively 
as seen in Table 2. 
To improve the method of analysis, a multiplex PCR was used in papers II-IV 
and primers detecting both VTI and VT2 gene sequences were added to the same 
reaction mixture. The MgCl2 concentration was changed to 2.5 mM, and 1.25 U 
Gold Taq (Applied Biosystems) was used. The thermocycling then started with 
10 min. of incubation at 94°C. The sensitivity of this new protocol was the same 
as before (data not shown). Even detection of the eaeA gene was by this time 
performed with Gold Taq with a prolonged incubation time initialising the 
thermocycling. 
Methods to detect VTI and VT2 
For verocytotoxicity testing, crude faecal cultures were tested for verocyto-
toxicity essentially performed as described by Clarke et al. (Clarke 1989). Crude 
cultures from sorbitol MacConkey agar plates were suspended in n utrient broth 
and incubated overnight at 37°C and then centrifuged at 7000 x g for 10 min. 
Fifty microlitres of supernatant was added to wells in a 96-well, flat-bottomed, 
microtitre plate. Each well contained fresh Vero cells and 100 |il of Eagle's 
minimal essential medium (Gibco, Sweden) supplemented with 5% foetal calf 
serum. The plates were incubated at 37°C in a 5% CO2 incubator for 48 hours 
and were examined directly under an inverted microscope to estimate the degree 
of destruction of the Vero cell monolayer. Wells having at least 50% destruction 
of the monolayer as compared to a standard control well, were considered posi­
tive. 
The direct toxin test (Premier Meridian Diagnostics, USA) was performed ac­
cording to the supplier's instructions. The plate method described in the instruc­
tions was used. 
PCR detecting VTI and VT2 genes applied to other bacteria 
To test the specificity of the PCR method for detection of EHEC, suspensions of 
species related to EHEC and other potential pathogens and commensals of the 
intestines were examined. These bacteria were all from the Culture Collection, 
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University of Göteborg, Sweden: Acinetobacter, CCUG 38560; Citrobacter 
freundii, CCUG 418; VT negative E. coli, CCUG 24; Enterobacter cloacae, 
CCUG 6323; Hafnia alvei, CCUG 38858; Klebsiella pneumophila, CCUG 
2715; Pseudomonas aeruginosa, CCUG 17619; Proteus mirabilis, CCUG 4637; 
Salmonella enteritidis, CCUG 32352; Shigella boydii, CCUG 9564; Shigella 
dysenteriae type 1, CCUG 39701; Shigella flexneri, CCUG 9506; Shigella 
sonnei, CCUG 9567; and Yersinia type 3, CCUG 8233. E. coli CCUG 29197, 
which gave a positive signal in PCR for both VT1 and VT2 producing sequen­
ces, was used as a positive control. 
PCR detecting the plasmid genes E-hly, etpD, katP and espP 
PCR for detection of the plasmid genes E-hly, etpD and katP was essentially 
performed as described earlier by Schmidt et al. (Schmidt 1999) in a thermal 
reactor (Omnigene, UK) using 2.0 U of Ampli Taq DNA polymerase (Applied 
Biosystems). Concentrations of primers, dNTP and MgCl2 in the reaction mix­
ture were as described above and in Table 2. Even the espP gene was detected 
by PCR. Primers espPl and espP3 were designed according to the nucleotide 
sequence reported by Brunder et al. (Brunder 1997) and found in the EMBL 
database library under accession number X97542. Amplification gave rise to an 
800 bp fragment. The PCR was performed in a total volume of 10 |il containing 
1 LIM of each primer and 1 (il Taq DNA polymerase (5lJ/ul; Applied Biosys­
tems) diluted 1:12.5 in enzyme dilution buffer (10 raM Tris [pH 8.3], 2.5 mg of 
bovine serum albumin/ml [Labora, Göteborg, Sweden]). The concentrations of 
MgCl2 and dNTP were as described above and in Table 2. The amplification 
was performed in a thermal reactor (Rapid cycler; Idaho Technology, Bio-
tech.IgG A/S, Copenhagen, Denmark) under conditions also described in Table 
2. 
Positive control for detection of the plasmid genes was kindly provided by Dr. 
H. Schmidt, Institut far Hygiene und Mikrobiologie, Würzburg, Germany. 
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PCR for detection of fimA, papC, sfaD/sfaE, daaE, iutA and 
hlyA. 
PCR to indicate P, S and type 1 fimbriae, as well as the genes coding for aero-
bactin and a-hemolysin, was mainly performed as described by Nowrouzian et 
al. (Nowrouzian 2001). Briefly, the reaction mixture contained the same ingre­
dients as described above although the amount of primers detecting the hlyA 
gene was 20 pmol. The thermal reactor used was Omnigen (UK). 
Primers to detect F1845 in the DR family of adhesins by PCR were designed in 
house. The primers were designed according to the nucleotide sequence reported 
by S. Bilge (Bilge 1993a). The PCR was performed in a total volume of 50 jll 
using 2 U of Taq DNA polymerase and the other conditions for the PCR reac­
tion as described above and in Table 2. The thermal reactor used for amplifica­
tion was an Omnigen (UK). Positive control for detection of these adhesin genes 
and the genes encoding aerobactin and a-hemolysin was kindly provided by F. 
Nowrouzian, Department of Clinical Bacteriology, Göteborg University, 
Sweden. 
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Serogrouping 
For 0157, the E. coli test kit, Oxoid LTD (Hampshire, England), was used. 
Positive control isolate of serogroup 0157 was CCUG 29197B. Serogrouping of 
other than 0157 was performed as previously described by Lidin-Janson et al. 
(Lidin-Janson 1977) or by the Laboratory of Enteric Pathogens, Central Public 
Health Laboratory, Colindale, England (Gross 1985). 
PFGE (pulsed-field gel electrophoresis) 
PFGE was used to establish clonal relatedness and diversity among isolates 
(papers I-IV). Each isolate was grown overnight in 5 ml tryptic soy broth, and 
250 jal of the suspension was prepared according to the method described by 
Gautom (Gautom 1997). The DNA was digested with 20 U of Xbal enzyme in 
200 |il of the appropriate restriction enzyme buffer following electrophoresis 
performed with the Gene Path system (Bio-Rad Laboratories, Sweden). The 
program used, was recommended by the supplier: no. 22 (Eco 157), with initial 
switch time 2.2 sec., final switch time 54.2 sec., run time 22 hours, angle 120°C, 
gradient 6.0 V/cm, temperature 14°C and a linear ramping factor. 
The PFGE patterns were interpreted according to the methods of Tenover et al. 
(Tenover 1995). Patterns differing by three bands or less were considered related 
to or probably related to each other. The gels were also digitised for computer-
aided analysis. The Molecular Analyst software package (Bio-Rad Laboratories) 
was used for analysis. Calculation of the similarity matrix was done with the 
Jacquard algorithm after defining each band between sizes 145 and 582 kbp. 
The clustering was achived with the unweighted pair group method. 
Statistical methods 
Rates of the presence of virulence factors in comparison to different groups of E. 
coli isolates were calculated using Fisher's exact test (results, this thesis and 
papers I and IV). 
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RESULTS 
Methodological investigations 
Adjustment of the PCR assay (I, II, III, IV) 
In paper I, amplification of the genes coding for VT 1 and VT2 was carried out 
in separate reactions. 1.0 pg of EHEC template DNA was clearly visible when 
visualized in an ethidiumbromid stained agarose gel. This is equivalent to 
approximately 200 genome copies, assuming a genome size of 4,600 kbp. Even 
the primers eaeA/ and eaeAr detecting the eaeA gene sequence gave a clearly 
visible band of the expected size after amplification of this amount of template 
DNA. 
To test the specificity of the PCR method for detection of EHEC, even other hu­
man pathogens or species genetically related to E. coli and commensals of the 
intestines were examined. None of the bacteria tested gave any DNA fragment 
except Shigella dysenteriae type 1. 
In papers II, III and IV the amplification reaction detecting the VT genes was 
improved with a multiplex PCR detecting both VT 1 and VT2 genes simul­
taneously. This changes in methodology had no negative influence on the sensi­
tivity. 
PCR for screening of EHEC among patients with clinical symptoms 
(I, II, III, IV) 
Table 3 shows the results of PCR versus culture, direct toxin test, verocytotoxin 
test, exposure to EHEC-positive patients and development of clinical symptoms 
of EHEC infection among 3,948 patients (paper 1). Stool specimens for 55 
(1.4%) of the patients were positive by PCR for either or both VT1 and VT2 
producing sequences. EHEC were also detected by culture in 39 of the 55 stool-
specimens. Among the 16 patients whose first stool specimens were positive by 
PCR but negative by culture, eleven had symptoms of HUS, bloody diarrhoea, 
or diarrhoea. Five had no or only slight symptoms, but they had been exposed to 
EHEC positive patients who had been diagnosed by culture as well as by PCR. 
Five patients had clinical symptoms of EHEC together with positive verocyto-
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toxin test or direct toxin test (Table 4). No specimen was positive by culture but 
negative by PCR. When we assume that also the 16 patients for whom no posi­
tive culture was given but clinical data, verocytotoxin test result, direct toxin test 
result and/or epidemiological data indicated positivity the results gave a positive 
predictive value of 98% (55/56), a negative predictive value of 100% 
(3,892/3,892), sensitivity 100% (55/55) and specificity 99.97% (3,892/3,893). 
Table 3. Results of PCR versus culture, toxin test, verocytotoxin test, exposure to EHEC-
positive patients and development of clinical symptoms (from paper I) (Welinder-Olsson 
2000) 
No. of patients 
EHEC diagnosed by culture, direct 
toxin test, verocytotoxin test, 
exposure or clinical symptoms 
EHEC 
culture-
negative Total 
PCR Positive 55 1 56 a 
Negative 0 3892 3892b 
Total 55 c 3893 d 3948 
a Positive predictive value, 98% (55/56) 
bNegative predictive value, 100% (3892 of 3892) 
c Sensitivity, 100% (55 of 55) 
d Specificity, 99.97% (3892 of 3893) 
Table 4. Clinical symptoms and toxintest results among the 16 PCR positive culture negative 
specimens 
Clinical symptoms and positive 
Clinical symptoms and/or exposure to direct toxin test or 
EHEC-positive patients (n =11) verocytotoxin test (n = 5) 
2 HUS 
2 bloody diarrhoea 
3 diarrhoea 
4 symptom-free 
5 diarrhoea including 
1 with abdominal pain 
In the papers II and IV, the screening method was used to identify additional 
patients and EHEC isolates for further studies, as well as VTEC isolates from 
healthy cattle. 
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In paper number III, the power of the screening method during an outbreak 
situation in 1999 is presented. Fifty-nine members of the staff with more or less 
severe diarrhoea at a children's hospital in Göteborg were sampled. Eleven stool 
specimens were positive for VT2 by PCR, indicating EHEC infection (Fig. 2). 
No one was positive for VT1 and only staff members who had attended a party 
were EHEC positive. In 9 of the 11 specimens, individual colonies of verocyto-
toxin-producing E. coli were isolated by culture and these all agglutinated posi­
tive for serogroup 0157. Thirty-seven stool specimens were also analysed from 
in-patients during the time for the outbreak. Of these, two children who were 
admitted to the hospital due to diarrhoea and HUS respectively during the first 
week of September were diagnosed with E. coli 0157 infection. 
6 1 
31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 
Aug Sept (date of illness) 
EI37 persons gastrointestinal symptoms, party Aug 31 
• 22 persons gastrointestinal symptoms, not party Aug 31 
Fig. 2. EHEC outbreak among staff at a children's hospital. Date for onset of gastrointestinal 
symptoms for 59 of the staff members sampled. Thirty-seven of the 59 members had attended 
a party on 31 August. P in the columns indicate EHEC diagnosed by culture and/or PCR. 
(From paper III) (Welinder-Olsson 2004b). 
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PFGE for epidemiological typing (I, II, III, IV) 
In paper I, PFGE has been used for epidemiological typing of EHEC. 55 isolates 
from different patients were studied. Fig. 3 shows that EHEC 0157 with seven 
different PFGE patterns were identified during May - September 1997. Among 
these, we found 18 isolates with the same PFGE pattern, A. These isolates origi­
nated from a clone that caused an epidemic outbreak of EHEC on the west coast 
of Sweden during the late summer months. At the time for this epidemic out­
break additionally EHEC 0157 with three different PFGE patterns (C, E and F) 
from seven patients were isolated. Isolate E was both V'/'l and VT2 positive 
while the isolates C and F were just VT2 positive as the clone with pattern A. 
Isolates with PFGE patterns G, H and I were isolated from patients who had 
arrived in Sweden from other European countries no more than 2 weeks prior to 
producing their stool specimen. Patients harbouring strains with PFGE pattern 
A, E and F had not been outside Sweden the month before giving their stool 
specimen. No information was available from the patient with the PFGE pattern 
C. 
Time-axis showing month for isolation of EHEC 0157 of different PFGE 
patterns 
B i l l  
® » « s it ss s mm 
a • M 1 I I f H 8 • • • a n a  
May June July Aug Sept 
G • = H = C =1 a = A • = E ® = F 
Fig. 3. Capital letters indicates PFGE patterns. G, H and I are from patients having been 
abroad. 
In paper II, additional isolates of EHEC have been studied according to their 
PFGE pattern together with their serogroups (Fig. 4). Isolates with an identical 
or related PFGE pattern belong to the same serogroup. This is shown in PFGE 
patterns Ol 17 and 0121 as well as 0157. Typing with PFGE is, however, more 
discriminating than serogrouping as variants of a PFGE pattern are possible to 
discern within a serogroup. Isolates with different PFGE patterns belong to dif­
ferent serogroups. Eight isolates were non-typable into serogroup even though 
they were sent to the Laboratory of Enteric Pathogens (Colindale, UK), while 
three were not typeable into PFGE patterns. 
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The PFGE method has also been used to establish clonal relatedness and diver­
sity among strains when an outbreak seemed to have occurred at the children's 
hospital in Göteborg, paper III. All isolates from the staff that had attended the 
same party had the same PFGE pattern (Fig. 5). Isolates of EHEC from two chil­
dren, who were admitted to the hospital due to diarrhoea and HUS at the time of 
the outbreak had, however, different PFGE patterns compared to the outbreak 
strain and differed to that with nine and five bands respectively. 
i 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Fig. 5. PFGE patterns and dendrogram of EHEC 0157 isolated from 9 (no. 1-9) of the staff 
members at the children's hospital and from two children (no. 10-11 ) hospitalised at the time 
of the outbreak. 
In paper IV, the PFGE method has been used to establish that isolates of 
different clonality were studied. 
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AB 
AH 
AC 
AK 
V 
O 
:> 
T 2 
I 2 
I 
H 
AE 
M 
G 
X 
AG 
AG 2 
J 
AF 
K 
D 
Z 
N 
Y 
0 B 
B 2 
AD 
Fig. 4. Dendrogram of EHEC strains, both 0157 and non-0157, isolated from routine fecal 
specimens sent to the Bacteriological Laboratory of the Sahlgrenska University Hospital in 
Göteborg. The dendrogram was constructed with the use of the unweighted pair group 
method by comparison of Xbal PFGE patterns. (From paper II) (Welinder-Olsson 2002) 
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Patients and bacterial characteristics 
In this study, including specimens sampled during the years 1997-1999, 66% 
(44/67) of the specimens positive by both culture and PCR were of serogroup 
0157 and 34% (23/67) non-0157. During this time, there was however two out­
breaks of serogroup 0157, which increased the amount of this serogroup. Other 
serogroups identified were 08, 022, 046, 076, 091, 0117, Ol 18, 0121, 0145, 
E43478/86 and 5 OR (rough isolates) and four ON (non-type able isolates). In 
paper I, including 55 patients with PCR positive specimens both culturable and 
not culturable, EHEC caused 7 cases (13%) of HUS, 19 cases (35%) of bloody 
diarrhoea, 20 cases (36%) of diarrhoea and 9 persons (16%) were symptom-free. 
In paper II, which includes specimens from 67 patients both PCR and culture 
positive, 6 patients (9%) had HUS, 27 patients (40%) had bloody diarrhoea, 24 
patients (36%) diarrhoea and 8 persons (12%) were symptom-free or with 
unknown symptoms. Table 5 shows that it is a similar proportion of patients 
with severe symptoms among those who were contaminated by EHEC 0157 
compared to non-0157. 
The age of the patients spanned between 4 months and 74 years, but 38% 
(21/55) in paper I and 45% (30/67) in paper II were 3 years or less. In paper I, 
there was an equal amount of male and female patients. In paper II, 46% (31/67) 
of the patients were male and 54% (36/67) were female. 
Table 5. Gastrointestinal symptoms among patients compared to whether EHEC Ol 57 or 
non-0157 were isolated. 
0157 Non-O157 Symptom , f|.-. . §_ or. 
HUS 9% 9% 
Bloody diarrhoea 43% 39% 
Diarrhoea 39% 30% 
Symptom-free 9% 13% 
Symptoms not known - 9% 
Period of incubation and duration of symptoms (I, III) 
The outbreak in 1999 gave the opportunity to study the period of incubation for 
EHEC. The source of infection was identified as the food at a party, and party-
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members were interviewed about the onset of gastrointestinal symptoms. In nine 
of the EHEC-positive individuals, the incubation time was between 8 hours and 
10 days. One person, however, who was also EHEC-positive by both PCR and 
culture, reported first symptoms 16 days after the party (Fig. 2). 
In paper I, we show for how long patients' stool specimens may give a positive 
PCR result for the VT1 and VT2 genes together with positive results for culture, 
as most patients stool-specimens were analysed for EHEC more than once. 
About 70% (9/13) of the patients are still EHEC positive one week after their 
first stool specimen but within a month most specimens are negative. The 
longest period of time for a patient to harbour EHEC in the gut was 32 days. We 
did not obtain any additional samples from that patient and we do not know for 
how long the patient was EHEC-positive. One patient had two positive stool 
specimens, using both PCR and culture, three months apart but a negative 
specimen in-between and may have been reinfected otherwise the case was an 
example of long time faecal shedding. 
The presence of the eaeA gene in correlation to patient's symptoms (I, II) 
Most of the EHEC-positive patients had isolates that were positive for the eaeA 
gene sequence (including all of the HUS patients), i.e. 100% (44/44) of the 
EHEC 0157 and 61% (14/23) of the non-0157 (paper II). Among eleven 
patients with bloody diarrhoea just seven (64%) were, however, identified to be 
eaeA positive (Table 6). Furthermore, additionally one patient with bloody 
diarrhoea, from whom we did not manage to isolate the EHEC bacteria, had a 
stool specimen negative for eaeA, but positive for VT2 (paper I). 
The presence of the four plasmid genes in relation to patients' symptoms 
(ID 
All EHEC 0157 possessed the EHEC hly gene as well as the etpD gene cluster 
(Table 6). 95% (42/44) of the 0157 EHEC harbour the katP gene and 89% 
(39/44) the espP gene. The two isolates, that failed to produce an amplification 
product with primers detecting the katP gene, had different PFGE patterns. 
However, among the five isolates negative for the espP gene three have identical 
PFGE patterns. The 0157 E. coli were both from patients with milder symptoms 
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(or diarrhoea only) and from patients with severe symptoms such as bloody 
diarrhoea and HUS, even if they had isolates of EHEC possessing all four 
plasmid-encoded determinants, together with eaeA positivity and one or both of 
the VT genes. 
Among the 23 EHEC non-0157, presence of the plasmid genes is somewhat dif­
ferent than described above for the EHEC Ol57. 14/23 (61%) were E-hly posi­
tive, 2/23 (9%) were positive for the etpD gene cluster, 3/23 (13%) were posi­
tive for katP and 11/23 (49%) were espP positive. There is, however, a signifi­
cant correlation for the presence of E-hly and severe symptoms for EHEC non-
0157 (p=0.0094). Eleven of the patients from whom EHEC non-0157 was 
isolated had HUS or bloody diarrhoea. Ten of these (91%) harboured EHEC 
with the E-hly gene, while only 1/11 (9%), 1/11 (9%) and 6/11 (55%) harboured 
the etpD gene cluster, katP or espP genes respectively (Table 6). 
Table 6. VT and plasmid genes in EHEC 0157 and non-0157. 
Virulence 
gene 
0157 
(n=44) 
Non-O157 
(n=23) 
Non-O157 with 
BD and/or HUS* 
(n=ll) 
VT1 14% 52% 45% NS** 
VT2 100% 52% 55% NS 
eaeA 100% 61% 64% NS 
E-hly 100% 61% 91% p=0.0094 
etpD 100% 9% 9% NS 
katP 95% 13% 9% NS 
espP 89% 49% 55% NS 
* BD (bloody diarrhoea) or HUS (hemorrhagic uremic syndrome) 
** NS (not significant) 
Presence of other virulence genes in EHEC isolates of human origin (IV) 
Human EHEC isolates were analysed according to an additional six potential 
virulence genes beside the verocytotoxin genes, the eaeA gene and the plasmid 
borne genes E-hly, etpD, katP and espP. The EHEC isolates analysed, all have 
different PFGE patterns and 13 belong to serogroup 0157, while 18 are non-
0157 isolates. The six genes include four genes coding for proteins involved in 
the bacterial adhesion to host cells namely the P, S, Fl845 and type 1 fimbriae. 
40 
The two other genes are iutA and hlyA, coding for aerobactin and a-hemolysin, 
involved in the bacterial competition for iron (Table 7). 
All isolates of serogroup 0157 have the gene coding for type 1 fimbriae and 
89% (16/18) among the non-0157 EHEC harbour this gene. The two EHEC 
isolates not harbouring the gene coding for type 1 fimbriae have, however, the 
eaeA gene, and seven isolates not harbouring the eaeA gene have the gene 
coding for type 1 fimbriae. Just three isolates of human origin harbour any of the 
genes coding for P, S or F 1845 fimbriae. 
The gene iutA coding for aerobactin is more often present among non-0157 than 
EHEC 0157. Aerobactin is coded for by 44% (8/18) of the non-0157 isolates 
and 8% (1/13) of the 0157 isolates. The chromosomally encoded a-hemolysin 
is about as uncommon among isolates of serogroup 0157 as non-0157, 1/13 and 
1/18 respectively. However, 97% (32/33) of the human isolates harbour at least 
one of the genes E-hly, iutA or hlyA possibly involved in the support of iron. 
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Presence of virulence genes in VTEC isolated from healthy cattle (IV) 
Verocytotoxin producing E. coli isolates from cattle (one 0157 and 11 non-
0157) were also analysed by PCR concerning possession of the same eleven 
gene determinants also tested for among the human isolates (Table 7), namely 
the plasmid genes E-hly, etpD, katP and espP, the genes coding for the adhesins 
intimin, P, S, F1845 and type 1 fimbriae and the genes coding for a-hemolysin 
and aerobactin. The isolate of serogroup 0157 is, besides VT2 positive, also 
positive for eaeA, E-hly, etpD, espP and for the genes coding for type 1 fim­
briae. Concerning EHEC non-0157, 18% (2/11) were eaeA positive and 45% 
(5/11) were E-hly positive. Six isolates (55%) were espP positive. None of the 
isolates originating from cattle was katP positive. 
No isolate originating from cattle has the genes coding for P or S fimbriae or the 
fimbrial adhesin F1845. All but one isolate have, however, the gene coding for 
type 1 fimbriae. No isolate has the gene coding for a-hemolysin and 17% (2/12) 
have the gene coding for aerobactin. 50%, (6/12) isolates with cattle origin, 
harbour any of the genes E-hly, intA or hlyA. 
Differences concerning virulence factors between human and cattle isolates 
(IV) 
Enclosing both EHEC 0157 and non-0157, the eaeA gene is to a significantly 
higher degree more often present among isolates of human than cattle origin 
(24/31 vs 3/12, p=0.0035). Additionally, 97% (30/31) of the human isolates 
have at least one of the genes E-hly, iutA or hlyA, which is to a significantly 
higher extent than found among isolates from cattle, among these 50% (6/12) 
harbour any of these genes (p=0.0009). 
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DISCUSSION 
Several recent outbreaks of gastrointestinal disease caused by EHEC have high­
lighted the threat these organisms pose to public health (Bell 1994, Cowden 
1997, Fukushima 1999, Welinder-Olsson 2004b). Outbreaks of this art have the 
potential to overwhelm acute-care resources, even in countries with advanced 
health care systems. Our capacity to control EHEC disease in humans and to 
limit the scale of outbreaks is dependent upon fast and correct diagnosis and 
identification of the source of infection. In this thesis, molecular biological tech­
niques have been tested and shown to be very useful in this purpose. As it has 
been obvious that EHEC is a heterogeneous group of bacteria, which beyond the 
production of verocytotoxins probably also have other virulence factors, PCR 
has been used for screening of other potential virulence genes. The thesis also 
includes a description of an outbreak of EHEC, which caused a great deal of 
trouble both among staff and patients as well as to the health care system. With 
the use of prompt molecular biological methods, it could be quickly identified 
and the consequences could be limited. 
Importance of fast and adequate identification of EHEC 
PCR is increasingly accepted to be the most sensitive means of determining 
whether a faecal specimen or a food sample contains EHEC. Although direct 
extracts of faeces or foods can be used as templates for PCR, the best results are 
usually obtained by testing extracts after primary culture (Gannon 1992, Paton 
1993, Begum 1995). Even though the laboratory looses some time for diagnosis, 
it is important to have a high sensitivity as the amount of EHEC is often veiy 
low in human faeces. In this thesis, we use a PCR, which detects 200 genome 
copies. This has shown to be sensitive enough to detect one single EHEC colony 
spiked in human faeces specimens. 
PCR, with the primers used in this thesis, has a high sensitivity and specificity. 
Assuming that not only the patients with positive cultures were infected with 
EHEC but also the 16 patients for whom only clinical data, the verocytotoxin 
test result, the direct toxin test result and/or epidemiological data verified the 
PCR results, the overall sensitivity of PCR was 100% (55/55) as well as the 
specificity (3,892/3,893). The positive predicted value was 98% (55/56) and the 
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negative predicted value was 100% (3,892/3,892). The sensitivity of culture was 
only 71% (39/55) even though the culture procedure is usually preceded by a 
positive PCR result and great efforts were made to find the bacteria harbouring 
the VT genes. 
There should be no doubt anymore, that it is important to be able to identify not 
only EHEC Ol57 but also the non-0157 EHEC (Paton 1998b, Schmidt 1999, 
Welinder-Olsson 2000, Welinder-Olsson 2002). Nevertheless there are still 
studies published that do not include these serogroups. As Bettelheim and 
Beutin (Bettelheim 2003) argue, there should be no excuse for a reasonable sized 
hospital, veterinary or food laboratory not to be able to detect the presence of 
EHEC of any serogroup in a sample. Methods which only rely on detection of 
EHEC 0157 and not on the other EHEC serogroups (Feldsine 2002a, Feldsine 
2002b) perpetuate the false myth of the uniqueness of this serogroup and the 
true incidence and ecology of EHEC will be underestimated. 
Papers I and II contribute to the understanding and knowledge that EHEC of 
several serogroups are pathogenic. They identify at least ten additional patho­
genic serogroups and approximately just as many that are non-typeable regard­
ing serogroups. Methods that are directed to identify the VTs or their genes are 
important and identification of sorbitol negative E. coli of serogroup 0157 is not 
sufficient. In paper II, only 30% of the non-0157 EHEC were sorbitol negative. 
If the only identification procedure was culture for sorbitol negative isolates on 
SMAC agar plates followed by positive 0157 agglutination, we would have 
misidentified 26 patients specimens, as seen in paper I. Four of these patients 
had HUS, seven had bloody diarrhoea, eleven had diarrhoea, and four had no 
symptoms. In paper II, which only includes both PCR and culture positive 
specimens even enclosing the PCR and culture positive specimens from paper I, 
44 EHEC were 0157 isolates and 23 EHEC were non-0157. There was a larger 
number of EHEC 0157 partly because there had been additionally one outbreak 
of EHEC of this serogroup. It also illustrates that, sorbitol negative EHEC 0157 
are easier to identify and distinguish from the other commensals in the faeces 
flora. The proportion of patients with HUS, bloody diarrhoea, diarrhoea or 
patients who are symptom-free are almost the same in patients having EHEC of 
serogroup 0157 or EHEC non-0157. 
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Over time, several different PCR methods have been used (Johnson 1990, 
Pollard 1990, Brian 1992, Gannon 1992, Begum 1993). The PCR method has to 
be easy to perform to be useful for screening for EHEC positive specimens. 
Complex PCR reactions involving primers detecting several virulence genes at 
the same time (Paton 1998a) increase the risk for mismatches and loss of 
sensitivity, together with problems when analysing the agarose gel. However, in 
recent years new developments in PCR technology, such as using fluorescence 
for the identification and verification of PCR products have made the PCR-
technique even more useful, and easy to perform (Heid 1996, Wittwer 1997, 
Bellin 2001, Pulz 2003). It is, however, still important to identify the VT gene 
harbouring organism by culture, as even Shigella dysenteriae type 1 harbour the 
gene sequence identified by the primers in PCR. 
Other techniques that involve the identification of VTs, are either protein 
detection by cytotoxicity assays or enzyme-linked immunosorbent assay 
(ELISA). Cytotoxicity assays are the most sensitive methods for detecting active 
VTs (Paton 1998b), but they are cumbersome to perform and are therefore not 
very useful for routine microbiology diagnosis. VT specific ELISAs are an 
alternative, they are however less sensitive than PCR (Beutin 1998) and are also 
known to generate some false positive results (Ball 1996, Beutin 1996a). 
Period of incubation and duration of symptoms 
For proper epidemiological considerations, it is important to know the average 
period of incubation. The incubation period earlier reported ranges from I to 9 
days (mean is 3.1 to 3.9 days) during community outbreaks (Riley 1983, Ostroff 
1990, CDC Centers for Disease Control. 1991) and from 1 to 14 days (mean is 4 
to 8 days) in institutional settings (Ryan 1986, Carter 1987, Su 1995). In the out­
break situation described in paper III, the period of incubation was between 1 
and 16 days with a median of 8 days. Such a long incubation period as 16 days 
is not earlier reported, still it was found unlikely that person to person transmis­
sion between personnel has occurred a this institutional setting. 
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E. coli infection has been linked to ingestion of food and drink contaminated 
with faecal material from bovine sources (Riley 1983, Swerdlow 1992). In some 
cases, however, EHEC has been transmitted directly from person to person. One 
important factor in direct transmission is how long an infective person sheds the 
pathogen. Only a few studies have however focused on this. From the studies in 
paper I, it can be concluded that 70% (9/13) of the patients from whom a second 
specimen was analysed within a week of the first positive specimen were still 
EHEC positive as determined by PCR. One month after the first positive speci­
men, most patients were negative. Karch et al. (Karch 1995) have done a similar 
analysis of serial stool specimens collected from patients infected with EHEC 
0157. Positivity was, however, only analysed by culture. It revealed that in 68% 
of the patients, only the first culture was 0157 positive, and the three cultures 
that followed, collected at 2- to 4-day intervals, were negative. In other words 2-
4 days after the first positive specimen, 68% of these patients were EHEC 
culture negative. The longer period of shedding shown in our study is probably 
explained by the more sensitive PCR procedure that we used. 
Karch et al, like us, identified patients who were long-term shedders. Three 
weeks or more after the onset of symptoms, they were still able to identify 
EHEC 0157 from 7 out of 53 patients (13%). We identified about the same 
proportion, 5/40 (12.5%) including one specimen from a patient sampled the 
fifth week after the first positive specimen and one patient with a positive 
specimen 3'A months after the first positive specimen with a negative specimen 
inbetween. To identify healthy carriers of EHEC by screening for bacteria 
harbouring the genes coding for the VTs, we identified only 2 positive out of 
400 patients specimen (0.5%), indicating that there are few healthy carriers in 
Sweden. 
PFGE for epidemiological typing of EHEC 
Typing of EHEC for epidemiological purposes is critical to identify an outbreak 
and to stop further spread of the organism. It was speculated by MP Doyle 
(University of Georgia) that EHEC 0157:H7 probably emerged some 30-40 
years ago when E. coli acquired bacteriophages that carried genes encoding two 
Shiga-like toxins (Konowalchuk 1977, Rowe 1995). If this is true, it is not sur-
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prising that these phylogenetically young organisms have only a few charac­
teristics that can be used to distinguish one isolate from another. Grif et al. 1998 
(Grif1998) made a comparative study of five different techniques for epidemio­
logical typing of is. coli 0157. They found that the methods phage typing, ribo-
typing two types of RAPD and PFGE, all had their shortcomings but underlined 
the great value of PFGE as a subtyping system with patterns that tend to be 
stable in outbreaks. Although single-band differences have previously been de­
scribed with PFGE among isolates from epidemiologically associated cases 
(Bender 1997), the discriminating power was as high as for phage typing. 
In the present thesis, we have used PFGE both for EHEC 0157 as well as for 
non-0157. The method was used for epidemiological purposes as well as to se­
cure that different clones of EHEC were studied when possible virulence factors 
of different isolates were compared. 
In paper I and II, it was shown that between May and September 1997 there 
were seven different clones of EHEC 0157 isolated. Five of these were isolated 
during August and September, one of which was from a patient who had been 
abroad. 
PFGE was especially useful during an outbreak situation at the children's hos­
pital in Göteborg. It was important to assess that it was an ongoing outbreak 
among the staff and that neither of the two children who were admitted to the 
hospital at the time for the outbreak were infected during their stay at the 
hospital. 
The EHEC isolates described in paper I and II showed a la rge variety of PFGE 
patterns among both EHEC 0157 and non-0157, which demonstrated a great 
clonal diversity. This is in agreement with the findings reported by Rios et al. 
(Rios 1999), who have studied the clonal diversity among isolates of Chilean 
isolates of EHEC, serogroup 026, Olli and 0157, from patients with different 
severities of symptoms. Consequently, PFGE provides sufficient information 
about clonal diversity and is one of the better methods of choice for epidemio­
logical investigations both for isolates of EHEC 0157 and non-0157. Inte-
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restingly there was some correlation between PFGE patterns and plasmid gene 
composition as shown in paper II. 
PFGE is especially useful for epidemiological investigations in a limited 
geoghraphic area handled by a laboratory in close connection with the personnel 
who have the epidemiological knowledge. International comparison of EHEC, 
which may be of interest, places high demands on inter-laboratory reproducibili­
ty that are not so easy to achieve. Although there is software which transform 
bands mathematically to numerical values, PFGE and other banding pattern-
based methods are not communicateable enough. 
However, sequencing of the complete bacterial genomes, including the sequence 
of two E. coli 0157:H7 isolates has given Lindstedt et al. (Lindstedt 2003) the 
opportunity to search the genomes for Variable Number of Tandem Repeats 
(VNTRs) in E. coli 0157:H7 that could be used as a source of genetic polymor­
phisms and be used in a typing assay. VNTRs for typing purposes have in recent 
years also been tested in some other bacterial species for example Yersinia pestis 
(Adair 2000, Klevytska 2001, Le Fleche 2001) and Mycobacterium tuberculosis 
(Frothingham 1998, Supply 2000, Le Fleche 2002, Skuce 2002). Lindstedt et al. 
found multiple-locus variable-number tandem-repeats analysis (MLVA) to be 
faster than PFGE and, accordingly, less labour intensive with yet slightly higher 
discriminatory power. Additionally, it has the benefit compared to PFGE and 
other banding pattern based methods that it has the potential for fully automating 
the analysis. Additionally, it leaves no moments for bias due to manual handling 
and gives the opportunity to be highly communicateable. 
Additional virulence factors beside the verocytotoxin genes 
Virulence factors in EHEC have mainly been studied in EHEC 0157. As we be­
lieve that all VT producing E. coli with the opportunity to find a niche in the 
human intestine could be harmful, we have characterised both EHEC 0157 and 
EHEC non-0157 concerning the presence of the two different VT genes and 
other presumptive virulence factors encoded by chromosomal as well as plasmid 
genes. The fact that the incidence of EHEC infection in humans is relatively low 
even though a fairly high amount of cattle, the principal reservoir of EHEC, 
50 
harbour VT producing strains, suggests that Shiga-like toxin production alone 
may not be sufficient for EHEC infection. Additional factors that appear 
necessary for virulence of EHEC 0157 are the locus for enterocyte effacement 
(LEE) and the large plasmid p0157. Characterization of EHEC isolates by use 
of PCR provides detailed information about genetic variability. This information 
together with epidemiological investigations are important to improve our 
understanding of the distribution of possible virulence genes among various 
EHEC serogroups of animal and human origin. 
In our investigation, all EHEC 0157 harboured the gene coding for VT2, and a 
few also harboured the VT1 coding sequence. The eaeA gene coding for intimin 
was also always present and, with few exceptions, the plasmid harbouring the E-
hly, etpD, katP and espP genes. The genes coding for VT1 and VT2 are more 
equally distributed among the non-0157 EHEC. About 60% harboured the eaeA 
gene coding for intimin and 50% of them were VT1 positive and 50% VT2 
positive. Accordingly, there was no correlation between eaeA positivity and the 
presence of the VT2 gene sequence as suggested by Boerlin et al. (Boerlin 
1999). In contrast to EHEC 0157, the non-0157 EHEC often failed to give an 
amplification product of the four plasmid-borne determinants, at least not all 
four simultaneously. The most predominantly determinant was the E-hly 
sequence (61% positive), followed by the espP sequence (48% positive) the 
katP sequence (13% positive) and the etpD sequence (8.7% positive). Still, 
EHEC non-0157 seems to be as pathogenic as EHEC 0157. There was approxi­
mately the same procentual amount of patients with HUS and bloody diarrhoea 
among patients infected with EHEC 0157 as with non-0157. There is, however, 
a significant correlation (p=0.0094) between severe symptoms such as HUS or 
bloody diarrhoea and the presence of the E-hly gene sequence among patients 
infected with EHEC non-0157. Thus, the results indicate, what has also been 
shown by others, that the EHEC-hemolysin may represent an interesting 
virulence marker for EHEC involved in severe human disease (Schmidt 1995, 
Beutin 1996b, Schmidt 1996a, Sandhu 1997). 
The presence of eaeA did not clearly correlate to pathogenicity. Even though the 
two HUS patients had EHEC positive for eaeA, there were five patients with 
bloody diarrhoea not harbouring the gene. It has been generally believed that 
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there is a strong association between carriage of eaeA and the capacity of EHEC 
to cause severe human disease. Studies have shown that the proportion of eaeA 
positive isolates is much higher in isolates from patients with severe disease in 
comparison to VTEC from animals (Barrett 1992, Beutin 1993, Beutin 1995, 
Sandhu 1996). The eaeA gene is, however, present among a relatively high de­
gree of the patient isolates (61%), which probably illustrates that it is important 
not necessarily for the severity of the symptoms but to contribute to the 
colonization of the human gut. This is in accordance with earlier observations 
that there are isolates of EHEC from patients suffering from HC and HUS that 
do not contain the eaeA gene (Barrett 1992, Louie 1994, Paton 1999). 
No correlation could be found between the presence of the espP gene and 
severity of symptoms even though there were quite a few EHEC non-0157 har­
bouring this gene or the etpD and katP genes which, however, are relatively rare 
among these kind of isolates. Even though many non-0157 EHEC have a plas-
mid similar to p0157 our results are in agreement with Brunder et al. in that the 
plasmids of EHEC are not uniform genetic elements but heterogenous in their 
gene composition (Brunder 1999). 
As we have isolated EHEC from patients with more or less severe symptoms, 
not harbouring the genes coding for intimin or enterohemolysin, efforts have 
been made to identify other genes that could possibly be a substitution for these 
genes. In this thesis, there has been a focus on genes involved in the adherence 
of EHEC to enterocytes and to genes possibly involved in the bacterial 
competition for iron. 
PCR with primers detecting the genes coding for P, S, F1845 and type 1 fim­
briae was used to identify adhesin genes other than eaeA, coding for intimin. 
The P, S and F1845 fimbriae were all very rare among both EHEC 0157 and 
non-0157. On the contrary, the majority of EHEC harbour the type 1 fimbriae, 
100% (13/13) of the 0157 and 89% (16/18) of the non-0157 EHEC. Even if the 
majority of EHEC have the gene coding for type 1 fimbriae in coexistence with 
the eaeA gene, nine EHEC non-0157 had either the gene coding for type 1 fim­
briae or the gene coding for intimin and there was no isolate of EHEC that did 
not have at least one of these two genes. Type 1 fimbriae cannot be a substitute 
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for intimin that mediates the intimate attachment of EHEC to the intestinal 
epithelial cell membrane, which also includes loss of microvilli. Type 1 fimbriae 
may, however, contribute to the ability to cause disease by supporting the bacte­
rial presence in the human intestine where it has been shown to bind to small 
and large intestinal epithelial cells (Wold 1988, Adler berth 1995). 
PCR, with primers detecting the genes coding for aerobactin and a-hemolysin, 
was performed to detect factors other than E-hly possibly involved in the bacte­
rial competition for iron. Among EHEC 0157, isolates harbouring genes coding 
for aerobactin or a-hemolysin are rare. Only 1 out of 13 isolates have either the 
gene iutA or hlyA. This is not surprising since these isolates all have a plasmid 
harbouring the gene coding for EHEC-hemolysin. Probably, at least one of the 
ways that the enterohemolysin contributes to the pathogenesis of EHEC is that 
haemoglobin released by the action of E-hly provides a source of iron. This is 
also supported by Torres and Payne who, in 1997, identified and cloned a gene 
encoding an iron-regulated haem-transport protein and showed that this E. coli 
haem-utilization gene (chuA) encoded an outer membrane protein that was syn­
thesized in response to iron limitation. Expression of this protein in a laboratory 
strain of E. coli 0157:H7 was sufficient for utilization of haem or haemoglobin 
as iron sources and it was highly homologous to the shuA gene of Shigella 
dys enter iae (Torres 1997). 
On the contrary we have found (paper IV) that the gene coding for aerobactin is 
rather common in EHEC non-0157. Interestingly, these isolates usually have 
either the iutA gene coding for aerobactin or the E-hly gene, rarely (in 3 out of 
18 isolates) both genes simultaneously. Taking EHEC 0157 and non-0157 
together 97% of the isolates possess at least one of the three genes coding for 
aerobactin, a-hemolysin or EHEC-hemolysin coding for traits affecting the iron 
support. A similar phenomenon was identified by Valvano et al. (Valvano 1986) 
when studying virulent neonatal E. coli Kl isolates. By comparison of the a-
hemolysin production with possession of the aerobactin system they found that 
all of the aerobactin-producing isolates did not synthesize a-hemolysin, whereas 
11 of 12 aerobactin-nonproducing isolates were haemolytic. Of the K1 strains 
examined, 92.5% possessed either the aerobactin system or the ability to 
produce a-hemolysin or both. 
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To strengthen the hypothesis concerning possible virulence factors in EHEC, 
verocytotoxin producing E. coli isolated from healthy cattle were analysed, as 
beef and dairy products are the most common source of human EHEC infection. 
There is a relatively low incidence of EHEC in comparison to a high presence of 
VTEC in cattle. The present thesis presents the results that VTEC non-0157 
isolated from cattle only in 18% harbour the eaeA gene in comparison to 61% 
among the human isolates. This is in agreement with previously reported results 
(Barrett 1992, Jenkins 2002). However, we have also shown among isolates 
from both humans and cattle that isolates not having the gene coding for intimin 
at least have the gene coding for type 1 fimbriae and vice versa. This may 
indicate that type 1 fimbriae is an important adhesin in the gut of both humans 
and cattle, while the eaeA gene is less valuable to obtain a niche in the intestines 
of cattle. As the gene coding for type 1 fimbriae and the eaeA gene are also 
often present in the same organism, it may also be the case that type 1 fimbriae 
can initiate adherence and make subsequent intimate adherence and A/E lesion 
formation more likely to occur. It has however been shown that the type 1 
fimbriae is not expressed in EHEC 0157 because of a gene deletion, while it is 
expressed in some studied EHEC non-0157 (Sherman 1987, Enami 1999, Roe 
2001). The presence of fimbriae on the surface of E. coli 0157:H7 has been 
reported by several investigators (Karch 1987, Toth 1990, Fratamico 1993, 
Elliott 2000), but their genetic representation and their molecular structure are 
still unknown. Some putative adhesin factors are now under investigation. In 
recent years, investigators have identified gene clusters both chromosomal, sfp 
and Iha-reactive protein, and in a plasmid, lpfAom, of isolates of EHEC that 
may function as adhesins (Brunder 2001, Schmidt 2001b, Doughty 2002). The 
chromosomal gene clusters are encoded by eaeA negativ EHEC Ol 13 and 
091 :H~ respectively and the plasmid gene was identified in a sorbitol fermenting 
EHEC O l 57: H . Even if the significance of these gene clusters is not yet fully 
understood, there are obviously additional adhesin gene clusters beside the LEE 
and type 1 fimbriae that could add to the capacity to adhere to human epithelial 
cells. 
None of the cattle isolates in this study harboured the gene sequences coding for 
P, S and F1845 fimbriae. Mainil et al. used a probe technique to study the 
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presence of F1845 and they made the same observation that F1845 is rare 
among VTEC isolates of cattle with diarrhoea (Mainil 1993). In a study per­
formed by Bertin et al. P and S fimbriae are found to be usual among E. coli 
isolated from cattle that suffer from diarrhoea. These isolates, however, belong 
to a group of E. coli that also produce CNF1 the cytoxic necrotizing factor type I 
but not verocytotoxin (Bertin 1998). Osek et al. have however made observa­
tions similar to the ones presented in this study as they found only a few isolates 
of VTEC with P fimbriae (Osek 2000). 
The most interesting difference between the human and cattle isolates as shown 
in the present thesis is, however, that only 45% of the cattle isolates harbour the 
genes E-hly, iutA and/or hlyA coding for traits affecting the iron support whereas 
97% of the human isolates possesses at least one of these determinants. We 
postulate that it i s important to have any of these traits for the competition for 
iron in the human gut, while it seems less important in the intestines of cattle. 
This difference is maybe also one of the reasons to the rather few incidences of 
human EHEC infection, in comparison to the relatively high frequency of VTEC 
in cattle. The difference also indicates the importance of aerobactin as a 
virulence factor of EHEC non-0157. It has previously been shown that the 
EHEC-hemolysin production and heme or hemoglobin utilization are factors 
more common to human isolates than to isolates from cattle (Law 1995). 
Moreover, Osek et al. found the same low number of VTEC harbouring E-hly as 
presented in our study among calves with diarrhoea (Osek 2000). The presence 
of the gene sequence enabling aerobactin syntheseis was however not studied 
and we believe that the expression of aerobactin or, to some extent, a-hemolysin 
contributes to the pathogenicity of EHEC non-0157. 
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CONCLUSIONS 
This thesis shows the importance of screening for EHEC among children and 
older patients with severe symptoms as HUS or bloody diarrhoea, identifying 
the VT genes. Using culture and 0157 agglutination only, half the amount of 
patients, probably even fewer, would have been identified. The PCR method 
detecting the VT genes appeared to be a fast, sensitive, and specific method. 
The period of incubation, which has said to be fairly short, was shown to be 
between 8 hours and 16 days. Within one week after the first positive EHEC 
specimen, about 70% (9/13) of the patients were still positive. 
PFGE was a well-suited method for epidemiological typing of EHEC both 0157 
and non-0157, and was more discriminative than serogrouping which had little 
value. 
Knowledge about virulence markers except for the VT genes is scarce. The eaeA 
and E-hly genes coding for intimin and EHEC-hemolysin seemed in these 
studies to be markers, beside the VT1 and VT2 genes, for the most virulent 
isolates of EHEC 0157 and non-0157. 
The eaeA, E-hly and iulA genes coding for intimin, EHEC-hemolysin and 
aerobactin, respectively, were present to a higher extent among human isolates 
than isolates from cattle. As the low frequency of EHEC in humans does not 
correspond to the high numbers of VT producing E. coli in the main source of 
infection, cattle, this fact may be one of the reasons why not all VT producing E. 
coli are pathogenic. Furthermore, aerobactin encoded by the gene iutA seemed 
to some extent to be able to compensate for the absense of EHEC-hemolysin in 
some isolates and the expression of aerobactin may therefore contribute to the 
virulence especial ly of EHEC non-0157. 
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